Ballew Advisors’s CME Group CME Stock Holding History

Ballew Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50	Closed	-$9K	–	145
2018 Q3	$9K	Buy	+50	New	+$8.42K	0.01%	299

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ballew Advisors's CME Position: Q4 2018 in Review

Ballew Advisors sold out of CME Group (CME) in Q4 2018, closing a stake of 50 shares — an estimated $9K sold.

Ballew Advisors first reported a position in CME in Q3 2018 and held it in 1 quarter. The position peaked at $9K in Q3 2018. 1,014 funds tracked by Wall St. Rank hold CME as of Q4 2018.

Ballew Advisors reported no remaining CME Group position as of Q4 2018 after selling out during the quarter.
Ballew Advisors sold 50 CME Group shares in Q4 2018, an estimated $9K.
Ballew Advisors first reported a position in CME Group in Q3 2018 and held it in 1 quarter.
Ballew Advisors's CME Group position peaked at $9K in Q3 2018.
1,014 funds tracked by Wall St. Rank held CME Group as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.